Brian Gonzalez Sanabia
Cardiovascular Disease · Ponce, PRNPI 1437649860
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 359 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 42.8% of the total.
Across 359 payments — averaging $27.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Medtronic$1K
- PBG Puerto Rico LLC$490
- AstraZeneca$365
- plus $1K from 11 others
What the payments were for
- Travel & lodging$330%
- Food & beverage$9,70097%
- Education$2482%
- Gifts$460%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 123 | $4,288 |
| Abbott | 58 | $1,332 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 57 | $1,121 |
| Medtronic | 34 | $1,055 |
| PBG Puerto Rico LLC | 27 | $490 |
| AstraZeneca | 12 | $365 |
| Johnson & Johnson | 15 | $264 |
| Amgen | 5 | $236 |
| Boehringer Ingelheim | 4 | $197 |
| E.r. Squibb & Sons, L.L.C. | 5 | $189 |
| Bayer Puerto Rico Inc. | 5 | $120 |
| Novartis | 5 | $107 |
| Merck | 4 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Chiesi USA, Inc. | 2 | $60 |
| Cordis US CORP. | 1 | $18 |
| Pfizer | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$312
- LUX-Dx Insertable Cardiac Monitor$251
- LifeVest$204
- COBALT DR MRI SURESCAN$175
- RESONATE EL ICD VR$151
- ONYX FRONTIER$135
- WATCHMAN Access System$129
- FARXIGA$125
- EMBLEM MRI S-ICD$125
- JARDIANCE$125
- Farapulse$121
- NA$109
- WATCHMAN FLX$107
- MERLIN@HOME$105
- Watchman$103
- Repatha$103
- GENERAL BRADY$101
- RESONATE$101
- Micra$100
How this compares
$10,026 in reported general payments places this provider in the 80th percentile of 267 cardiovascular disease providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $14,921 |
| FarxigaDapagliflozin Propanediol | 14 | $8,220 |
| BrilintaTicagrelor | 17 | $7,772 |
| Candesartan Cilexetil | 13 | $883 |
| Rosuvastatin Calcium | 55 | $689 |
| Metoprolol Succinate | 65 | $574 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 34 | $501 |
| Atorvastatin Calcium | 70 | $485 |
| ClopidogrelClopidogrel Bisulfate | 36 | $389 |
| Irbesartan | 18 | $385 |
| Losartan Potassium | 34 | $367 |
| Nifedipine ErNifedipine | 13 | $258 |
| Amlodipine Besylate | 70 | $245 |
| Carvedilol | 33 | $223 |
| Lisinopril | 57 | $213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Brilinta | $365 | $15,99231 claims |
| PfizerEliquis | $3 | $14,92123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 267 cardiovascular disease providers in Puerto Rico.
Other cardiovascular disease in Ponce
- Ulises Rodriguez RamosPonce$44K
- Edwin MolinaPonce$40K
- Edgardo Bermudez MorenoPonce$18K
- Vanessa Rodriguez MierPonce$14K
- Jose GomezPonce$8K
- Oscar Quintero-SerranoPonce$7K
- Gerardo Alayon AntaPonce$7K
- Karen Rodriguez MaldonadoMayaguez$231K
- Jose NovoaBayamon$209K
- Manuel GuzmanSan Juan$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.